2023 ASCOGI 食管胃癌进展highlights本资料仅限于回复专家的学术需求,由礼来公司医学部制作该资料信息可能包含在中国未批准的适应症,请严格按照处方资料用药该资料不可复制,不可散发,不作为临床用药指导礼来医学部 ONCO MS
Choose Specialty BRAIN CANCER BREAST CANCERBREAST CANCER GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS GENOMIC TESTINGGENOMIC TESTING GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS HEAD & NECK CANCERS HE...
Evolving Treatments in Hepatocellular Carcinoma: Updates from ASCO GI 2024 : Episode 4 Opinion Video March 4, 2024 EMERALD-1 Study: Significance as Presented at ASCO GI 2024Rachna Shroff, MD, MS, FASCO, highlights the prominence of the EMERALD-1 study for patients with HCC. EP: 1.Hepatocellul...
2024年美国临床肿瘤学会胃肠道肿瘤研讨会(ASCO GI 2024)于当地时间1月18～20日在旧金山召开。本次会议汇聚了世界各地的顶尖专家,共襄消化肿瘤盛举,共享学术研究盛宴。在当地时间18日的口头报告专场,美国纪念斯隆-凯特琳癌症中心(Memorial Sloan Kettering Cancer Center)Yelena Y. Janjigian教授汇报了MATTERHORN研究中FLOT...
Upper-GI highlights from ASCO and ASCO-GI 2023 meetings: changing paradigm in treatment sequence. memo 17, 87–91 (2024). https://doi.org/10.1007/s12254-023-00944-8 Download citation Received16 October 2023 Accepted30 November 2023 Published29 December 2023 Issue DateMay 2024 DOIhttps://doi...
当地时间5月31日~6月4日,2024年美国临床肿瘤学会(ASCO)年会在美国芝加哥召开,这是全球规模最大、级别最高、学界最权威的肿瘤学术会议之一。宾夕法尼亚大学的胃肠肿瘤学家Kim Reiss主持了上消化道肿瘤口头报告专场,会后,我们特邀Dr.Reiss点评今年ASCO大会上消化道肿瘤领域的“明星”研究。
July 06, 2024 1 min watch Save VIDEO: ‘More movement’ in nontransplant-eligible multiple myeloma population CHICAGO — In this video, Sandra Mazzoni, DO, highlights data in nontransplant-eligible patients with multiple myeloma presented at ASCO Annual Meeting. July 06, 2024 1 min read Save...
Background In 2024, an estimated 9,280 patients will be diagnosed with chronic myeloid...Gastroesophageal Cancer By Caroline Helwick / December 10, 2024: Supplement – Conference Highlights ESMO 2024 / ESMO Congress 2024 KEYNOTE-811: Pembrolizumab Combination in First-Line Setting Improves Overall...
Last year the field of immunotherapy was finally introduced to GI oncology, with several changes in clinical practice such as advanced hepatocellular carcinoma or metastatic colorectal MSI-H. At the virtual ASCO-GI symposium 2021, several large trial res
Today, we're bringing you some key highlights from the 2025 ASCO Gastrointestinal Cancers Symposium, and I'm delighted to be joined by the chair of GI25, Dr. David Wang. Dr. Wang is a GI medical oncologist at the University of Michigan. Our full disclosures are available in the ...